Market News AIOpen the app

MNOV stock news · MediciNova

Stories about MediciNova (MNOV) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for MNOV

Follow MediciNova (MNOV) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for MNOV
Free on the App Store and Google Play, or on the web.
  1. Sep 28, 2026, 1:14 PM ET · Market

    Here are 12 health care stocks that changed a lot during Monday's trading.

    Neutral

    MediciNova shares fell 32%, but the article gives no company news explaining the move. It does not change MediciNova's business outlook.

  2. Sep 28, 2026, 11:18 AM ET · Market

    MediciNova's drug didn't meet liver fat goals, causing its stock to drop.

    Neutral

    MediciNova reported stronger blood-fat measures and weight loss, but its liver-fat measure did not differ significantly from placebo. These mixed trial results leave the company's outlook unchanged.

  3. Sep 28, 2026, 8:23 AM ET · Market

    12 health care stocks are changing a lot before the market opens on Monday.

    Neutral

    The report says MediciNova shares fell 10.68% to $2.30 before trading. It gives no company news explaining the move, so the story does not change MediciNova's outlook.

  4. Sep 17, 2026, 1:15 PM ET · Market

    On Thursday, 12 health care stocks changed a lot, with Aethlon Medical jumping 330.8% and Longeveron dropping 57.3%.

    Neutral

    MediciNova's stock moved up, but the piece only lists the intraday gain and market cap, so this price action does not alter the company's picture.

  5. Aug 19, 2026, 7:34 AM ET · New boss

    Medicinova Inc details changes in leadership with the exit and election of directors, along with the appointment of new officers and their compensation arrangements (MNOV).

    Neutral

    Medicinova Inc has filed a Form 8-K detailing the departure and appointment of certain directors and officers, which could lead to shifts in company strategy and investor sentiment. The immediate implications of these changes warrant close attention from investors.